Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2020-04-01 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/03/2020. The content is focused on share capital changes and confirmations related to securities issuance. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the exchange, which fits the category of Regulatory Filings (RNS) as it is a compliance document reporting share capital changes and confirmations to the stock exchange, not a full report or announcement of a report publication.
2020-04-01 English
2019 Annual Results Announcement
Annual Report Classification · 95% confidence The document is titled '2019 Annual Results Announcement' and contains detailed consolidated financial statements including profit or loss, comprehensive income, and financial position for the year ended 31 December 2019. It includes extensive financial data, notes on accounting policies, and auditor's report information. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content corresponds to a comprehensive annual financial report covering the full fiscal year, which matches the definition of an Annual Report (10-K). There is no indication that this is merely an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the document is best classified as an Annual Report (10-K). FY 2019
2020-03-27 English
Date of Board Meeting
Report Publication Announcement Classification · 95% confidence The document is a short announcement from Guangdong Tannery Limited stating the date of a board meeting to consider and approve the audited annual results for the year ended 31 December 2019. It does not contain the actual annual report or financial data but merely announces the meeting date and agenda. The document length is only 1320 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing of report approval or publication are classified as Report Publication Announcements (RPA).
2020-03-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 29/02/2020. The content focuses on share capital changes, issuance, and confirmations related to securities issued during the month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting share capital movements and related confirmations to the stock exchange, consistent with regulatory compliance disclosures rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2020-03-02 English
Expected decrease in loss
Regulatory Filings Classification · 95% confidence The document is an announcement by Guangdong Tannery Limited regarding an expected decrease in loss for the year ended 31 December 2019. It is based on preliminary unaudited consolidated management accounts and explicitly states that the final audited results are still being finalized. The document is short (3969 characters) and serves as an inside information announcement under the Listing Rules and Securities and Futures Ordinance. It does not contain full financial statements or detailed financial analysis, but rather a summary of expected financial performance. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER) since it lacks comprehensive financial data and is preliminary. It is also not a Management Report (MDA) or Investor Presentation (IP) as it is a brief announcement. Given the nature and length, and that it is an announcement of expected financial results, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2020-02-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/01/2020. The content focuses on share capital changes and confirmations related to securities issuance. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements to the stock exchange, consistent with a Major Shareholding Notification or Share Issue/Capital Change. Given the detailed share capital movements and confirmations, the best fitting category is Share Issue/Capital Change (SHA). The document length is substantial and contains detailed data, so it is not a mere announcement or report publication notice.
2020-02-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.